← FDA DRUG APPROVALS

FDA ANDA · ANDA210401

ACYCLOVIR

Sponsor: YILING

APPLICATION
ANDA210401
TYPE
ANDA
ORIGINAL APPROVAL
2018-03-07
LATEST ACTION
2026-06-24
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

ACYCLOVIRPrescription
ACYCLOVIR 800MG · TABLET · ORAL
ACYCLOVIRPrescription
ACYCLOVIR 400MG · TABLET · ORAL

Approval history

2026-06-24Labeling · Supplement 5 · standardAP
2018-03-07UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →